A new report published by WHO in the lead-up to World Diabetes Day highlights the alarming state of global access to insulin and diabetes care.
It finds that high prices, low availability of human insulin, few producers dominating the insulin market and weak health systems are the main barriers to universal access.
WHO Director-General, Dr Tedros Adhanom Ghebreyesus said the scientists who discovered insulin 100 years ago refused to profit from their discovery and sold the patent for just one dollar.
He said, however that, the gesture of solidarity has been overtaken by a multi-billion-dollar business that has created vast access gaps.
Atiewin Mbillah-Lawson reports.